申请人:Angiogene Pharmaceuticals Ltd.
公开号:US07081469B2
公开(公告)日:2006-07-25
Vascular damaging agents composed of substituted 5(6)-substituted benzimidazole-2-carbamates are provided. These agents are useful in the preparation of medicaments for the treatment of diseases involving neovascularisation, particularly for the treatment of solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis. Embodiments include a 5(6)-substituted benzimidazole-2-carbamate of formula I
wherein A represents a multi-substituted alkyl group or aromatic ring.
提供了由取代的5(6)-取代苯并咪唑-2-氨基甲酸酯组成的血管破坏剂。这些剂对于制备治疗涉及新血管生成的疾病的药物特别有用,尤其是用于实体肿瘤、黄斑变性、糖尿病视网膜病变、类风湿性关节炎、银屑病和动脉粥样硬化的治疗。实施例包括式I的5(6)-取代苯并咪唑-2-氨基甲酸酯,其中A代表多取代的烷基或芳香环。